320 related articles for article (PubMed ID: 19021151)
1. Use of medications with anticholinergic properties and cognitive function in a young-old community sample.
Low LF; Anstey KJ; Sachdev P
Int J Geriatr Psychiatry; 2009 Jun; 24(6):578-84. PubMed ID: 19021151
[TBL] [Abstract][Full Text] [Related]
2. Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.
Uusvaara J; Pitkala KH; Tienari PJ; Kautiainen H; Tilvis RS; Strandberg TE
J Am Geriatr Soc; 2009 Mar; 57(3):427-31. PubMed ID: 19278396
[TBL] [Abstract][Full Text] [Related]
3. Anticholinergic drugs and physical function among frail elderly population.
Landi F; Russo A; Liperoti R; Cesari M; Barillaro C; Pahor M; Bernabei R; Onder G
Clin Pharmacol Ther; 2007 Feb; 81(2):235-41. PubMed ID: 17192773
[TBL] [Abstract][Full Text] [Related]
4. Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: a population-based study.
Cancelli I; Gigli GL; Piani A; Zanchettin B; Janes F; Rinaldi A; Valente M
J Clin Psychopharmacol; 2008 Dec; 28(6):654-9. PubMed ID: 19011434
[TBL] [Abstract][Full Text] [Related]
5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
6. A drug burden index to define the functional burden of medications in older people.
Hilmer SN; Mager DE; Simonsick EM; Cao Y; Ling SM; Windham BG; Harris TB; Hanlon JT; Rubin SM; Shorr RI; Bauer DC; Abernethy DR
Arch Intern Med; 2007 Apr; 167(8):781-7. PubMed ID: 17452540
[TBL] [Abstract][Full Text] [Related]
7. Cognitive decline in high-functioning older persons is associated with an increased risk of hospitalization.
Chodosh J; Seeman TE; Keeler E; Sewall A; Hirsch SH; Guralnik JM; Reuben DB
J Am Geriatr Soc; 2004 Sep; 52(9):1456-62. PubMed ID: 15341546
[TBL] [Abstract][Full Text] [Related]
8. Clock drawing interpretation scale (CDIS) and neuro-psychological functions in older adults with mild and moderate cognitive impairments.
Colombo M; Vaccaro R; Vitali SF; Malnati M; Guaita A
Arch Gerontol Geriatr; 2009; 49 Suppl 1():39-48. PubMed ID: 19836615
[TBL] [Abstract][Full Text] [Related]
9. Relation of serum anticholinergicity to cognitive status in schizophrenia patients taking clozapine or risperidone.
Tracy JI; Monaco CA; Abraham G; Josiassen RC; Pollock BG
J Clin Psychiatry; 1998 Apr; 59(4):184-8. PubMed ID: 9590669
[TBL] [Abstract][Full Text] [Related]
10. Adverse effects of anticholinergic activity on cognitive functions in Alzheimer's disease.
Konishi K; Hori K; Uchida H; Watanabe K; Tominaga I; Kimura M; Hosoyamada M; Shibasaki T; Kataoka A; Hachisu M
Psychogeriatrics; 2010 Mar; 10(1):34-8. PubMed ID: 20594285
[TBL] [Abstract][Full Text] [Related]
11. Use of drugs with anticholinergic effects and cognitive impairment in community-living older persons.
Merchant RA; Li B; Yap KB; Ng TP
Age Ageing; 2009 Jan; 38(1):105-8. PubMed ID: 19008305
[No Abstract] [Full Text] [Related]
12. Drug Burden Index and change in cognition over time in community-dwelling older men: the CHAMP study.
Jamsen KM; Gnjidic D; Hilmer SN; Ilomäki J; Le Couteur DG; Blyth FM; Handelsman DJ; Naganathan V; Waite LM; Cumming RG; Bell JS
Ann Med; 2017 Mar; 49(2):157-164. PubMed ID: 27763767
[TBL] [Abstract][Full Text] [Related]
13. Assessing cognitive effects of anticholinergic medications in patients with coronary artery disease.
Lanctôt KL; O'Regan J; Schwartz Y; Swardfager W; Saleem M; Oh PI; Herrmann N
Psychosomatics; 2014; 55(1):61-8. PubMed ID: 23993643
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and predictors of anticholinergic agents in elderly outpatients with dementia.
Bhattacharya R; Chatterjee S; Carnahan RM; Aparasu RR
Am J Geriatr Pharmacother; 2011 Dec; 9(6):434-41. PubMed ID: 22030114
[TBL] [Abstract][Full Text] [Related]
15. Anticholinergic drugs and functional outcomes in older patients undergoing orthopaedic rehabilitation.
Koshoedo S; Soiza RL; Purkayastha R; Mangoni AA
Am J Geriatr Pharmacother; 2012 Aug; 10(4):251-7. PubMed ID: 22795433
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal investigation of perceived control and cognitive performance in young, midlife and older adults.
Windsor TD; Anstey KJ
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2008 Nov; 15(6):744-63. PubMed ID: 18787982
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychological measures in normal individuals that predict subsequent cognitive decline.
Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M
Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935
[TBL] [Abstract][Full Text] [Related]
18. Urinary incontinence in older community-dwelling women: the role of cognitive and physical function decline.
Huang AJ; Brown JS; Thom DH; Fink HA; Yaffe K;
Obstet Gynecol; 2007 Apr; 109(4):909-16. PubMed ID: 17400853
[TBL] [Abstract][Full Text] [Related]
19. The effects of anticholinergic drugs on attention span and short-term memory skills in children.
Giramonti KM; Kogan BA; Halpern LF
Neurourol Urodyn; 2008; 27(4):315-8. PubMed ID: 17828786
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2.
Lopez OL; Jagust WJ; Dulberg C; Becker JT; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Jones B; Kawas C; Carlson M; Kuller LH
Arch Neurol; 2003 Oct; 60(10):1394-9. PubMed ID: 14568809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
